For citations:
Smirnov V.A., Khvostova M.A., Morozova Ya.V., Radaev S.M., Zuev S.E., Karanadze V.A., Barbakadze Z.A., Ryabov S.I., Zvyagintseva M.А., Bazanovich S.A., Kordonskiy A.Yu., Tsarev A.V., Talypov A.E., Grin A.A. Cell therapy for patients with severe spinal cord injury (phase I/IIа): Assessment of safety and primary efficacy of therapy. Russian journal of neurosurgery. 2025;27(2):43-69. https://doi.org/10.63769/1683-3295-2025-27-2-43-69
Views PDF (Eng): 37
Email this article 